Page 7 - Scientist Training Program News Today

A new UCLA-led study used a combination of new testing methods to identify multiple new risk genes for Alzheimer disease and a rare, related brain disorder ca

A new blood test can detect toxic amyloid beta oligomers associated with Alzheimer's disease years before symptoms appear.

In this narrative essay, a medical student discusses how observing a patient interacting with her adult daughter was a reminder of the ways in which the roles

Six University of Michigan scientists and engineers have been named the 2022 winners of the MBioFAR Award, which recognizes exceptional mid-career faculty in the biosciences. MBioFAR, which stands for Mid-career Biosciences Faculty Achievement Recognition, is an annual award established last year

Their genetic test involved screening for 290 genetic variants and could provide doctors an extra tool for estimating a person’s risk for prostate cancer.

Tapping into the Million Veteran Program, an ongoing national research effort to learn how genes, lifestyle and military exposures affect the health of participants, researchers at University of California San Diego School of Medicine and the VA San Diego Healthcare System, with colleagues elsewhere, report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer.

People who had surgery to remove half of the brain correctly recognized differences between pairs of words or faces more than 80% of the time.

A Stony Brook research team is working to improve CAR-T immunotherapy by shortening cell expansion and making it more cost-effective, accessible and timely for patients

/PRNewswire/ -- A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications....

A new UCLA-led study has identified multiple new risk genes for Alzheimer's disease and a rare, related brain disorder called progressive supranuclear palsy (PSP) by using a combination of new testing methods allowing for mass screening of genetic variants in a single experiment.